At ASCO, Vice President Joe Biden announced the launch of the first-of-its-kind, open-access cancer databases to allow researchers to better understand the disease and develop more effective treatments. Read More
At the annual meeting of the American Society of Clinical Oncology (ASCO) this month, progress was reported on experimental drugs that awaken the power of the immune system to destroy cancers. Several ACGT Research Fellows, Read More
Imlygic, the first gene therapy drug approved in the U.S. is used to treat advanced stage and recurrent melanoma. Read More
In 2012, Bob Levis, an Allentown, Pennsylvania resident, believed he had come to the end of his life. Diagnosed in 2002 with chronic lymphocytic leukemia, … Read More
“They took my cancer cells and irradiated them, and then injected them back into my body so my immune system would kick in,” Morrow said. Read More
I am an almost five year survivor of Stage IV NSCLC, adenocarcinoma. I attribute this amazing achievement to the grace of God, aggressive treatment and a “no stone left unturned” attitude. This attitude led me years ago to ACGT and the pioneering work of people like Dr. Jack Roth. Read More
Dr. Michael Lotze, Member of the Alliance for Cancer Gene Therapy Scientific Advisory Council speaks about progress in the research using cell and gene therapy … Read More
ACGT is the nation’s only non-profit exclusively dedicated to gene and cell therapies for treating cancer. To date, ACGT has provided over $24 million in grants … Read More
Dr. Michel Sadelain, ACGT Research Fellow, talks about the future of gene therapies for cancer treatment. When/Where: Alliance for Cancer Gene Therapy’s (ACGT) “Achieving Cancer … Read More
The mission of ACGT is to seek out and support revolutionary scientific research into the causes, treatment and prevention of all types of cancer using cells and genes as medicine.
Cell and gene therapies are destroying tumors every day in the laboratory and in human trials, targeting only the cancer with few side effects to healthy tissue. ACGT’s rigorous grant review process, under the guidance of a preeminent Scientific Advisory Council, have resulted in some of the most successful breakthroughs in the history of cancer treatments and led to many patients in complete remission.
100% of our funding supports innovation and translational science that is proving again and again to offer better treatment options than the traditional therapies of chemotherapy, surgery and radiation. Every donation brings us closer to saving lives and changing the way we treat cancer forever.